Completion rate and compliance of anti-tuberculosis chemoprophylaxis in patients with rheumatic disease receiving tumor necrosis factor antagonists.
Ideguchi
H
H
Ohno
S
S
Takase
K
K
Kirino
Y
Y
Suda
A
A
Ihata
A
A
Ueda
A
A
Takeno
M
M
Nagaoka
S
S
Ishigatsubo
Y
Y
D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance / Q000706:statistics & numerical data*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D018501:Antirheumatic Agents; D000995:Antitubercular Agents; D014409:Tumor Necrosis Factor-alpha